extraction of #26 with debridement, the patient continued to receive antibiotic coverage (Teicoplanin, 400 mg, Piperacillin/Tazobactam, 4 g/0.5 g) and steroid treatment (Solumedrol, 250 mg, q6h for 3 days, tapered to prednisolone 60 mg, qd). The swelling largely subsided on Day 5 after the surgery; however, vision improved only minimally. In the 4 th month of follow-up, entropion, absence of light perception and pupil light reflex, and minimal ophthalmoplegia were observed in the left eye ( Figures 1E and  1F ). In the past, septic dural sinus thrombosis was potentially lethal; however, antibiotics now offer a cure. 1 Certain vital structures, such as cranial nerves III, IV, VI, V1, and V2 and the internal carotid artery, pass through the cavernous sinus. The anatomical proximity of these structures explains the severe neurologic sequelae following SCST. 2 SCST treatments incorporate antibiotics, debridement, steroid, and anticoagulant therapy. 4 Antibiotic coverage should be implemented immediately once a diagnosis is established. Vancomycin combined with a third to fourth generation cephalosporin is recommended. Surgery is crucial for infection source removal. However, debridement of the cavernous sinus is infrequently executed because of unwarranted complications. 5 Steroids are used because of the antiinflammatory effect that is considered beneficial for the recovery of neurological deficits. 3 In this case, emergent antibiotics institution combined with interdisciplinary debridement prevented further sepsis progressing. We administered high-dose steroids and did not use anticoagulants on the insistence of the patient. Nevertheless, the left eye healed with some morbidity. Blindness, mydriasis, and mild ophthalmoplegia indicated damage of cranial nerves II, III, and IV, respectively. We presumed that severe swelling and compression of the extraocular muscles compromised the surrounding blood supply to the optic nerve. Awareness of these unfamiliar sequelae of maxillofacial infection should be emphasized.
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